Home › Funds › Birchview Capital, LP › CMPX
Birchview Capital, LP position in CMPX
COMPASS THERAPEUTICS INC · Health Care
Birchview Capital, LP reported holding 1,575,000 shares of CMPX (COMPASS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.97% of its reported portfolio and ranking #26 among its reported holdings. Birchview Capital, LP has disclosed CMPX holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Birchview Capital, LP's CMPX position evolved
Birchview Capital, LP first disclosed a stake in CMPX in Q1 2025 at 24,000 shares (US$46K). The position peaked in Q4 2025 at 1,592,938 shares, worth US$8.6M. Across 6 filings, Birchview Capital, LP increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,575,000 shares valued at US$1.6M — a reduction of -100,000 shares quarter over quarter.. Notable position changes include a 82% increase in Q4 2025 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 24.00K | $45.60K | New |
| Q3 2025 | 872.94K | $3.06M | New |
| Q4 2025 | 1.59M | $8.55M | Add |
| Q1 2026 | 1.47M | $7.75M | Reduce |
| Q2 2026 | 1.68M | $3.67M | Add |
| Q3 2026 | 1.57M | $1.64M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CMPX and 13F data
CMPX (COMPASS THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in CMPX — the largest reported positions include TANG CAPITAL MANAGEMENT LLC (US$39.4M), ORBIMED ADVISORS LLC (US$33.3M), MONTANOVA CAPITAL, LLC (US$30.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CMPX
- TANG CAPITAL MANAGEMENT LLC 17.99M sh · $39.40M · Q2 2026
- ORBIMED ADVISORS LLC 15.22M sh · $33.33M · Q2 2026
- MONTANOVA CAPITAL, LLC 14.10M sh · $30.88M · Q2 2026
- Enavate Sciences GP, LLC 7.79M sh · $17.06M · Q2 2026
- Palo Alto Investors LP 5.83M sh · $12.77M · Q2 2026
- Vivo Capital, LLC 3.42M sh · $3.56M · Q3 2026
More on Birchview Capital, LP
FAQ
How long has Birchview Capital, LP held CMPX?
Birchview Capital, LP has disclosed CMPX holdings in 6 of the last 7 reported quarters, going back to Q1 2025.
What is Birchview Capital, LP's current position in CMPX?
As of Q3 2026, Birchview Capital, LP holds 1.57M shares of CMPX (COMPASS THERAPEUTICS INC), valued at $1.64M, representing 0.97% of its reported portfolio and ranking #26.
Has Birchview Capital, LP been buying or selling CMPX?
In the latest 13F filing (Q3 2026), Birchview Capital, LP reduced its position in CMPX. The position peaked in Q4 2025 at 1.59M shares.
Which other funds hold CMPX?
Other major institutional holders of CMPX include TANG CAPITAL MANAGEMENT LLC, ORBIMED ADVISORS LLC, MONTANOVA CAPITAL, LLC, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.